Catalyst Wire Dossier Catalyst Wire Dossier

Durezol

difluprednate · Sirion Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Durezol, covering 2006-11-30 to 2013-06-19. Get the full timeline:

Most recent: Clinical Trial Update: Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery [Phase 3]

See pricing